Skip to content

The effects of intravenous sedative agents combined therapy for pediatrics

The sedative effects of propofol-ketamine combination in children with hemato-oncologic malignancy undergoing bone marrow aspiration and biopsy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0001606
Enrollment
120
Registered
2015-08-31
Start date
2014-12-26
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : We apply three options of drug combination respectively with randomized control. As for three options, first, propofol only(total 20ml)
2mg per kilogram: second, PK25( propofol 150mg mix with ketamine 50mg
total 20ml) 0.25ml per kilogram
PK20 (propofol 160mg mix with ketamine 40mg: total 20ml) 0.25ml per kilogram. Before procedure, we give fantanyl 1.5cc per kilogram at first, then give each designated regimen to patient. During proce

Sponsors

The Catholic University of Korea, Seoul St. Mary's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Pediatric patients who are scheduled to do bone marrow aspiration and biopsy in outpatient clinic.

Exclusion criteria

Exclusion criteria: less than 10 kilogram or over 40 kilogram in body weight the pediatrics who have upper respiratory infection or fever. the pediatrics who take the anticonvulsant or have neurologic abnormalities the pediatrics who have prior sensitization or allergic to propofol, soy, egg products, or ketamine the pediatrics who take the medicine related to current sedative agents the pediatrics who already take the sedatives or analgesics the refusal of participation in this study by parents

Design outcomes

Primary

MeasureTime frame
The frequency of adverse repiratory events during procedures

Secondary

MeasureTime frame
the number of movement during procedure ;the duration from the end of procedure to emergence(awake);the adverse events by sedative agents

Countries

Korea, Republic of

Contacts

Public ContactHYUNJUNG Koh

The Catholic University of Korea, Seoul St. Mary's Hospital

uglyko@hanmail.net+82-2-2258-6156

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026